尖吻蝮蛇毒磷脂酶A2基因的克隆与序列分析

从尖吻蝮蛇毒腺中抽提总ＲＮＡ,经ＲＴＰＣＲ扩增磷脂酶Ａ２的基因,以江浙蝮蛇的酸性磷脂酶Ａ２基因为探针杂交筛选克隆,分离得到４种磷脂酶Ａ２基因。经双向测序测定了这些磷脂酶Ａ２同功酶基因的全序列,并由此推导出编码的氨基酸序列。运用计算机软件推算了它们的等电点,按照等电点和结构特征将它们分别命名为尖吻蝮蛇毒酸性磷脂酶Ａ２Ｉ（Ａ．ａＡＰＬＡ２Ｉ）、尖吻蝮蛇毒酸性磷脂酶Ａ２ＩＩ（Ａ．ａＡＰＬＡ２ＩＩ）、尖吻蝮蛇毒碱性磷脂酶Ａ２（Ａ．ａＢＰＬＡ２）和尖吻蝮蛇毒Ｌｙｓ４９磷脂酶Ａ２（Ａ．ａＬｙｓ４９ＰＬＡ２）。其中Ａ．ａＡＰＬＡ２Ｉ的１～１０位氨基酸残基序列同以前分离得到的尖吻蝮蛇酸性磷脂酶Ａ２已测定的１～１０位氨基酸残基序列完全一致。Ａ．ａＬｙｓ４９ＰＬＡ２基因则由于其推导出的４９位氨基酸残基由Ｌｙｓ代替了Ａｓｐ而区别于以前克隆到的磷脂酶Ａ２基因。最后运用计算机软件比较了它们的同源性。这一组磷脂酶Ａ２基因的克隆,将为进一步研究磷脂酶Ａ２的结构与功能的关系提供更多的信息。     

江浙蝮蛇磷脂酶A2基因的多样性研究

我们利用简并引物从江浙蝮蛇腺总ＲＮＡ经ＲＰ－ＰＣＲ扩增磷脂酶Ａ２（简称ＰＬＡ２）基因,并以碱性ＰＬＡ２（Ｂ－ＰＬＡ２）基因为探针,分离出了酸性ＰＬＡ２（Ａ－ＰＬＡ２）和两个未见报道的特征结构类同的基因,分别命名为Ａｓｎ＾４８－ＰＡＬ２和ＢＡ－ＰＡＬ２。双向测序测定了这组ＰＬＡ２同工酶（除信号肽外）基因的全序列,并由此推导编码的氨基酸序列。其中Ａ－ＰＬＡ２基因编码的氨基酸序列与较早报道的由蛇毒中分离     

江浙蝮蛇血清中天然神经解毒因子的分离纯化及性质鉴定

江浙蝮蛇（ＡｇｋｉｓｔｒｏｄｏｎｈａｌｙｓＰａｌａｓ）是属于蝮科蝮属的有毒蛇。蝮蛇毒成份比较复杂，但其中所含的蝮蛇神经毒素（ａｇｋｉｓｔｒｏｄｏｔｏｘｉｎ，ＡＴＸ），是主要的神经毒性成分，它具有磷脂酶Ａ２（ＰＬＡ２）活性，是一种阻碍神经肌肉接头传递的...     

江浙蝮蛇毒碱性磷脂酶A2单斜晶体的培养和晶体学研究

江浙蝮蛇毒碱性磷脂酶Ａ_２单斜晶体的培养和晶体学研究牛秀田,孟五一,桂璐璐,王小强,林政炯（中国科学院生物物理研究所生物大分子国家重点实验室,北京１００１０１）顾培忠,周元聪（中国科学院上海生物化学研究所,２０００３１）关键词江浙蝮蛇毒碱性磷脂酶Ａ_２...     

江浙蝮蛇毒酸性磷脂酶A2基因的表达

将江浙蝮蛇毒酸性磷脂酶Ａ２基因克隆至表达载体ｐＢＬＭＶＬ２,转化入大肠杆菌ＲＲ１,经过温敏诱导,ＳＤＳ－Ｐ;ＡＱＧＥ检测,在约１４ｋＤ处有一表达条带。表达产物酸性磷脂酶Ａ２约占细菌蛋白总量的３０％,并以包涵体的形式存在。纯化包涵体后,将产物变性,复性,然后用ＦＰＬＣ Ｓｕｐｅｒｏｓｅ＾ＴＭ１２纯化,产物经过ＳＤＳ－ＰＡＧＥ检测只有单一条带。     

江浙蝮蛇毒酸性磷脂酶A2抑制制血小板作用的机理

江浙蝮蛇毒酸性磷脂酶Ａ２（ＡＰＬＡ２）对多种致聚剂引起的血小析具有抑制作用,这种抑制并非是由于ＡＰＬＡ２与血小板膜结合,引起膜流动性降低造成。ＡＰＬＡ２不裂解血小板,电镜观察表明它能抑制血小析部颗粒的中心化,使之不易被激活。进一步研究显示ＡＰＬＡ２是作用在骨架上,使致聚剂引肌动蛋白单体聚合难以进行,ＡＰＬＡ２导致的ｃＡＭＰ浓度的升高正说明了这点。结果提示ＡＰＬＡ２首先作用于轿小板细胞膜,引起ｃＡＭ     

江浙蝗蛇毒酸性磷脂酶A_2抑制血小板作用的机理

江浙蝮蛇毒酸性磷脂酶Ａ２（ＡＰＬＡ２）对多种致聚剂引起的血小板聚集具有抑制作用,这种抑制并非是由于ＡＰＬＡ２与血小板膜结合,引起膜流动性降低造成。ＡＰＬＡ２不裂解血小板,电镜观察表明它能抑制血小板内部颗粒的中心化,使之不易被激活。进一步研究显示ＡＰＬＡ２是作用在细胞骨架上,使致聚剂引起的朋动蛋白单体聚合难以进行,ＡＰＬＡ２导致的ｃＡＭＰ浓度的升高正说明了这点。结果提示ＡＰＬＡ２首先作用于血小板细胞膜。引起ｃＡＭＰ浓度升高,影响到细胞骨架的正常功能,进而抑制了血小板的聚集。     

尖吻蝮蛇毒酸性磷脂酶A_2I的表达及其生化特征

将尖吻蝮蛇毒酸性磷脂酶 Ａ２ Ｉ（ Ａ．ａ Ａ Ｐ Ｌ Ａ２ Ｉ） 的基因克隆至表达载体ｐ Ｂ Ｌ Ｍ Ｖ Ｌ２ , 在大肠杆菌 Ｒ Ｒ１ 中成功表达。表达产物 Ａ．ａ Ａ Ｐ Ｌ Ａ２ Ｉ约占细菌蛋白质总量的３０ ％ , 以包含体的形式存在。纯化包含体后, 将产物变性、复性, 然后用 Ｆ Ｐ Ｌ Ｃ Ｓｕｐｅｒｏｓｅ Ｔ Ｍ１２ 纯化, 产物经过 Ｓ Ｄ Ｓ Ｐ Ａ Ｇ Ｅ 检测只有单一条带。对表达的 Ａ．ａ Ａ Ｐ Ｌ Ａ２ Ｉ进行了酶活性、抑制血小板聚集活性和溶血活性的测定。结果显示, 表达的 Ａ．ａ Ａ Ｐ Ｌ Ａ２ Ｉ的酶活性同变性后复性江浙蝮蛇酸性磷脂酶 Ａ２（ Ａ Ｐ Ｌ Ａ２） 的酶活性相近, 既具有抑制血小板聚集活性也具有溶血活性。最后对磷脂酶 Ａ２（ Ｐ Ｌ Ａ２） 的结构与这些活性的关系进行了讨论     

尖吻蝮蛇酸性磷脂酶A2的纯化和初步晶体学

为进一步揭示影响血小板聚集活性的结构基础,纯化了江西尖吻蝮蛇（Ａｇｋｉｓｔｒａｄｕｎ ａｃｕｔｕｓ）酸性磷脂酶Ａ２。江西省吻蝮蛇蛇毒经ＣＭ－Ｓｅｐｈａｒｏｓｅ离子交换柱层析,两步ＤＥＡＥ－Ｓｅｐｈａｒｏｓｅ离子交换柱层析以及Ｍｏｎｏ）ＧＦＰＬ离子交换柱层析,得到了ＳＤＳ聚丙烯酰胺凝胶电泳和等和集电泳均一的磷脂酶Ａ２（ＰＬＡ２）,其分子量为１６．５ＫＤ,等电点为４．３,经测定,该酶具有抑制ＡＤＰ诱地     

尖吻蝮蛇毒酸性磷脂酶A2泊表达及其生化特征

将尖吻蝮蛇毒酸性磷脂酶Ａ２Ｉ（Ａ．ａＡＰＬＡ２Ｉ）的基因克隆至表达载体ｐＢＬＭＶＬ２,在大肠杆菌ＲＲ１中成功表达,表达产物Ａ．ａＡＰＬＡ２Ｉ约占细菌蛋白质总量的３０％,以包含体的形式存在。纯化包含体后,将产物变性,复性,然后用ＦＰＬＣ Ｓｕｐｅｒｏｓｅ ＾ＴＭ１２纯化,产物经过ＳＤＳ－ＰＡＧＥ检测只有单一条带。     

Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom

A platelet aggregation inhibitor phospholipase A(2) (NND-IV-PLA(2)) was isolated from Naja naja (Eastern India) venom by a combination of cation and anion exchange chromatography. NND-IV-PLA(2) is the most catalytically active enzyme isolated from the Indian cobra venom. The acidic PLA(2) profile of Eastern regional Indian cobra venom is distinctly different from that of the western regional venom. However the acidic PLA(2)s from both the regions follow the pattern of increasing catalytic activity with increase in acidic nature of the PLA(2) isoform. NND-IV-PLA(2) is a Class B1 platelet aggregation inhibitor and inhibits platelet aggregation induced by ADP, collagen and epinephrine. Modification of active site histidine abolishes both catalytic activity and platelet aggregation inhibition activities while aristolochic acid, a phospholipase A(2) inhibitor has only partial effect on the two activities.     

Lysosomal phospholipase A2

Lysosomal phospholipase A2 (PLA2G15) is a ubiquitous enzyme uniquely characterized by a subcellular localization to the lysosome and late endosome. PLA2G15 has an acidic pH optimum, is calcium independent, and acts as a transacylase in the presence of N-acetyl-sphingosine as an acceptor. Recent studies aided by the delineation of the crystal structure of PLA2G15 have clarified further the catalytic mechanism, sn-1 versus sn-2 specificity, and the basis whereby cationic amphiphilic drugs inhibit its activity. PLA2G15 has recently been shown to hydrolyze short chain oxidized phospholipids which access the catalytic site directly based on their aqueous solubility. Studies on the PLA2G15 null mouse suggest a role for the enzyme in the catabolism of pulmonary surfactant. PLA2G15 may also have a role in host defense and in the processing of lipid antigens for presentation by CD1 proteins. This article is part of a Special Issue entitled Novel functions of phospholipase A2 Guest Editors: Makoto Murakami and Gerard Lambeau.     

Kinetic and structural properties of disulfide engineered phospholipase A2: insight into the role of disulfide bonding patterns

The family of secreted 14 kDa phospholipase A(2) (PLA2) enzymes have a common motif for the catalytic site but differ in their disulfide architecture. The functional significance of such structural changes has been analyzed by comparing the kinetic and spectroscopic properties of a series of disulfide mutants engineered into the sequence of pig pancreatic IB PLA2 to resemble the mammalian paralogues of the PLA2 family [Janssen et al. (1999) Eur. J. Biochem. 261, 197-207, 1999]. We report a detailed comparison of the functional parameters of pig iso-PLA2, as well as several of the human homologues, with these disulfide engineered mutants of pig IB PLA2. The crystal structure of the ligand free and the active site inhibitor-MJ33 bound forms of PLA2 engineered to have the disulfide bonding pattern of group-X (eng-X) are also reported and compared with the structure of group-IB and human group-X PLA2. The engineered mutants show noticeable functional differences that are rationalized in terms of spectroscopic properties and the differences detected in the crystal structure of eng-X. A major difference between the eng-mutants is in the calcium binding to the enzyme in the aqueous phase, which also influences the binding of the active site directed ligands. We suggest that the disulfide architecture of the PLA2 paralogues has a marginal influence on interface binding. In this comparison, the modest differences observed in the interfacial kinetics are attributed to the changes in the side chain residues. This in turn influences the coupling of the catalytic cycle to the calcium binding and the interfacial binding event.     

Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venom gland

The phospholipase A2 (PLA2, E.C. 3.1.1.4) superfamily is defined by enzymes that catalyze the hydrolysis of the sn-2 bond of phosphoglycerides. Most PLA2s from the venom of Bothrops species are basic proteins, which have been well characterized both structurally and functionally, however, little is known about acidic PLA2s from this venom. Nevertheless, it has been demonstrated that they are non-toxic, with high catalytic and hypotensive activities and show the ability to inhibit platelet aggregation. To further understand the function of these proteins, we have isolated a cDNA that encodes an acidic PLA2 from a cDNA library prepared from the poly(A)+ RNA of venom gland of Bothrops jararacussu. The full-length nucleotide sequence of 366 base pairs encodes a predicted gene product with 122 amino acid with theoretical isoelectric point and size of 5.28 and 13,685 kDa, respectively. This acidic PLA2 sequence was cloned into expression vector pET11a (+) and expressed as inclusion bodies in Escherichia coli BL21(DE3)pLysS. The N-terminal amino acid sequence of the 14 kDa recombinant protein was determined. The recombinant acidic PLA2 protein was submitted to refolding and to be purified by RP-HPLC chromatography. The structure and function of the recombinant protein was compared to that of the native protein by circular dichroism (CD), enzymatic activity, edema-inducing, and platelet aggregation inhibition activities.     

Phospholipases A2 from Callosellasma rhodostoma venom gland cloning and sequencing of 10 of the cDNAs, three-dimensional modelling and chemical modification of the major isozyme.

Callosellasma rhodostoma (Malayan pitviper) is a monotypic Asian pitviper of medical importance. Three acidic phospholipases A2 (PLA2s) and one basic PLA2-homolog were purified from its venom while 10 cDNAs encoding distinct PLA2s were cloned from venom glands of a Thailand specimen of this species. Complete amino-acid sequences of the purified PLA2s were successfully deduced from their cDNA sequences. Among the six un-translated PLA2 cDNAs, two apparently result from recombination of its Lys49-PLA2 gene with its Asp49-PLA2 genes. The acidic PLA2s inhibit platelet-aggregation, while the noncatalytic PLA2-homolog induces local edema. This basic PLA2-homolog contains both Asp49 and other, unusual substitutions unique for the venom Lys49-PLA2 subtype (e.g. Leu5, Trp6, Asn28 and Arg34). Three-dimensional modelling of the basic protein revealed a heparin-binding region, and an abnormal calcium-binding pocket, which may explain its low catalytic activity. Oxidation of up to six of its Met residues or coinjection with heparin reduced its edema-inducing activity but methylation of its active site His48 did not. The distinct Arg/Lys-rich and Met-rich region at positions 10-36 of the PLA2 homolog presumably are involved in its heparin-binding and the cell membrane-interference leading to edema and myotoxicity.     

Modeling of acanthoxin A1, a PLA2 enzyme from the venom of the common death adder (Acanthophis antarcticus)

The phospholipase A2 enzyme, acanthoxin, found in the venom of the common death adder (Acanthophis antarcticus) as with other snake PLA2 enzymes displays neurotoxic activity. It is unclear whether this neurotoxic activity particular to some snake PLA2 enzymes is a result of structural differences solely within the catalytic sites or at a distant location upon the molecules. We have predicted the three-dimensional structure of one of the two predominant isoforms of acanthoxin (A1) using comparative protein modeling techniques. Given the high degree of homology and the availability of a high quality crystallographic structure, notexin was used as a molecular template to construct an all atom model of acanthoxin. The model was made using the program MODELLER3 and then refined with X-PLOR. Comparison between the predicted structure of acanthoxin and several X-ray structures of toxic and nontoxic PLA2 enzymes has led to a testable two-step proposal of neurotoxic PLA2 activity; involving the favorable binding to acceptor molecules followed by enzymatic intrusion upon the target membrane. The electrostatic potentials across the molecular surfaces of toxic and nontoxic PLA2 enzymes were calculated (GRASP) and it was found that the toxic PLA2 enzymes possessed a charge distribution on the noncatalytic surface not identified in the nontoxic PLA2 enzymes. Thus we have identified residues potentially involved in the interaction of the PLA2 enzymes with their acceptor molecules. Furthermore, the proposed acceptor molecule recognition site is distant from the catalytic site which upon binding of the PLA2 to the acceptor molecule may enhance the enzymatic ability of the toxic PLA2 enzymes on particular cell types.     

Comparative study of three phospholipase A2s from the venom of Vipera aspis

1. Three phospholipase A2s, PLA2-I, PLA2-II and PLA2-III, were isolated from Vipera aspis venom by gel filtration and ion exchange chromatography. 2. Purified PLA2-I, -II and -III have mol. wts of 30,200, 16,000 and 13,500, and isoelectric points of 9.45, 7.65 and less than 4.1, respectively. 3. PLA2-I consists of an acidic subunit (mol. wt 13,700, pI: less than 3.5) and a basic subunit (mol. wt 16,500, pI: 10.6), which can be separated under highly acidic conditions. 4. PLA2-I possessed lethal activity and LD50 for this preparation was estimated to be 0.288 (0.209-0.397) micrograms/g, while lethality was not observed when PLA2-II, -III or each subunit of PLA2-I were administered. 5. Capillary permeability-increasing activity was found in the samples which possessed basic isoelectric points. Additionally, PLA2-I and its basic subunit drastically prolonged activated partial thromboplastin time of platelet rich plasma. 6. Intramuscular injections of PLA2-I, -II and -III increased serum creatine phosphokinase activity in mice, indicating that damage in muscle was caused by these enzymes. 7. NH2-terminal sequences of the three PLA2s were compared with other phospholipase A2s from snake venoms. Furthermore, antigenicities were tested using antiserum prepared against each sample.     

Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive

We have solved the 1.55 A crystal structure of the anion-assisted dimer of porcine pancreatic group IB phospholipase A2 (PLA2), complexed with the products of hydrolysis of the substrate platelet activating factor. The dimer contains five coplanar phosphate anions bound at the contact surface between the two PLA2 subunits. This structure parallels a previously reported anion-assisted dimer that mimics the tetrahedral intermediate of PLA2 bound to a substrate interface [Pan, Y. H., et al. (2001) Biochemistry 40, 609-617]. The dimer structure has a molecule of the product acetate bound in subunit A and the other product 1-octadecyl-sn-glycero-3-phosphocholine (LPC-ether) to subunit B. Therefore, this structure is of the two individual product binary complexes and not of a ternary complex with both products in one active site of PLA2. Protein crystals with bound products were only obtained by cocrystallization starting from the initial substrate. In contrast, an alternate crystal form was obtained when PLA2 was cocrystallized with LPC-ether and succinate, and this crystal form did not contain bound products. The product bound structure has acetate positioned in the catalytic site of subunit A such that one of its oxygen atoms is located 3.5 A from the catalytic calcium. Likewise, a longer than typical Ca-to-Gly(32) carbonyl distance of 3.4 A results in a final Ca coordination that is four-coordinate and has distorted geometry. The other oxygen of acetate makes hydrogen bonds with N(delta)(1)-His(48), O(delta)(1)-Asp(49), and the catalytic assisting water (w7). In contrast, the glycerophosphocholine headgroup of LPC-ether in subunit B makes no contacts with calcium or with the catalytic residues His(48) or Asp(49). The tail of the LPC-ether is located near the active site pocket with the last nine carbons of the sn-1- acyl chain refined in two alternate conformations. The remaining atoms of the LPC-ether product have been modeled into the solvent channel but have their occupancies set to zero in the refined model due to disorder. Together, the crystallographic and equilibrium binding results with the two products show that the simultaneous binding of both the products in a single active site is not favored.     

Solution structure of porcine pancreatic phospholipase A2.

The lipolytic enzyme phospholipase A2 (PLA2) is involved in the degradation of high-molecular weight phospholipid aggregates in vivo. The enzyme has very high catalytic activities on aggregated substrates compared with monomeric substrates, a phenomenon called interfacial activation. Crystal structures of PLA2s in the absence and presence of inhibitors are identical, from which it has been concluded that enzymatic conformational changes do not play a role in the mechanism of interfacial activation. The high-resolution NMR structure of porcine pancreatic PLA2 free in solution was determined with heteronuclear multidimensional NMR methodology using doubly labeled 13C, 15N-labeled protein. The solution structure of PLA2 shows important deviations from the crystal structure. In the NMR structure the Ala1 alpha-amino group is disordered and the hydrogen bonding network involving the N-terminus and the active site is incomplete. The disorder observed for the N-terminal region of PLA2 in the solution structure could be related to the low activity of the enzyme towards monomeric substrates. The NMR structure of PLA2 suggests, in contrast to the crystallographic work, that conformational changes do play a role in the interfacial activation of this enzyme.     

1H-NMR and protection studies of interactions between ligands and bovine pancreatic phospholipase A2

A number of long-chain amines and naphthylamine sulfonates have been studied for their ability to inhibit bovine pancreatic phospholipase A2 (PLA2) and to protect PLA2 against alkylation of the active site histidine by p-bromophenacyl bromide. Their areas of interaction on the enzyme were further delineated using observations of chemical shift changes of assigned aromatic signals in the 1H-NMR spectrum of PLA2, while the bound conformations of two amine inhibitors were revealed using transferred nuclear Overhauser effects. The alkyl amines bind rather non-specifically on the surface of the enzyme, over the active site cleft and the interface recognition site.